MarketCap
Facebook
X
Telegram
Xylem Income Statement 2025-2008 | XYL
Brief overview of revenue and earnings at Xylem
The comparison covers a five-year financial horizon. Revenue at Xylem moved from 4.9 billion dollars in 2020 to 9 billion dollars in 2025. Across the full period, sales moved by +85.3%; the average annual rate was 13.1%. The pace indicates confident and sustained business growth.
At the gross-profit level, the result moved from 1.8 billion dollars to 3.5 billion dollars, a change of +89.9%. There was no major divergence between sales and cost of revenue. Comparing the endpoints gives gross margins of 37.5% and 38.5%. There was no meaningful shift in gross profitability.
The operating result measured by EBITDA moved from $618 million to $1.8 billion, or +190.9%. Operating profitability strengthened faster than the scale of sales. Comparing the endpoints gives EBITDA margins of 12.7% and 19.9%. The increased EBITDA share is a positive sign.
Net profit was $254 million at the start and $957 million at the end. The period finished with its strongest net-income result.
The five-year change in capitalization reached +73.4%: from 18.1 billion dollars to 31.3 billion dollars. The financial trend was stronger than the market valuation.
Conclusion
The results point to consistent and sustainable progress. The positive side is supported by net-income growth, a larger revenue base and positive operating leverage. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Xylem
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
31.3 B | 31.4 B | 27.3 B | 18.5 B | 21.5 B | 18.1 B | 13.8 B | 12.9 B | 13.1 B | 8.87 B | 6.5 B | 6.24 B | 6.18 B | 5.19 B | 4.8 B | - | - | - |
Shares |
243 M | 243 M | 217 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 179 M | 181 M | 183 M | 185 M | 186 M | 185 M | 185 M | 185 M | - |
Historical Prices |
129 | 129 | 126 | 102 | 119 | 100 | 76.6 | 64 | 64.7 | 46.3 | 33.7 | 34.6 | 31 | 23.8 | 22.2 | |||
Net Income |
957 M | 890 M | 609 M | 355 M | 427 M | 254 M | 401 M | 549 M | 331 M | 260 M | 340 M | 337 M | 228 M | 297 M | 279 M | 329 M | 263 M | - |
Revenue |
9.04 B | 8.56 B | 7.36 B | 5.52 B | 5.2 B | 4.88 B | 5.25 B | 5.21 B | 4.71 B | 3.77 B | 3.65 B | 3.92 B | 3.84 B | 3.79 B | 3.8 B | 11 M | - | - |
Cost of Revenue |
5.56 B | 5.35 B | 4.65 B | 3.44 B | 3.22 B | 3.05 B | 3.2 B | 3.18 B | 2.86 B | 2.31 B | 2.25 B | 2.4 B | 2.34 B | 2.29 B | 2.34 B | 1.99 B | 1.81 B | - |
Gross Profit |
3.48 B | 3.21 B | 2.72 B | 2.08 B | 1.98 B | 1.83 B | 2.05 B | 2.03 B | 1.85 B | 1.46 B | 1.4 B | 1.51 B | 1.5 B | 1.5 B | 1.46 B | 1.21 B | 1.04 B | - |
Operating Income |
1.22 B | 1.01 B | 652 M | 622 M | 585 M | 367 M | 486 M | 654 M | 552 M | 408 M | 449 M | 463 M | 363 M | 443 M | 395 M | 388 M | 276 M | - |
Interest Expense |
18 M | 16 M | 49 M | 50 M | 76 M | 77 M | 67 M | 82 M | 82 M | 70 M | 55 M | 54 M | 55 M | 55 M | 17 M | - | 1 M | - |
EBITDA |
1.8 B | 1.57 B | 1.09 B | 858 M | 830 M | 618 M | 743 M | 937 M | 815 M | 587 M | 588 M | 631 M | 559 M | 624 M | 534 M | 480 M | 346 M | - |
Operating Expenses |
- | - | - | - | - | - | - | 1.35 B | 1.27 B | 1.02 B | 949 M | 1.02 B | 1.09 B | 1.02 B | 1.06 B | - | - | - |
General and Administrative Expenses |
1.92 B | 1.91 B | 1.76 B | 1.23 B | 1.18 B | 1.14 B | 1.16 B | 1.16 B | 1.09 B | 915 M | 854 M | 920 M | 986 M | 914 M | 964 M | 737 M | 667 M | - |
All numbers in USD currency
Quarterly Income Statement Xylem
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
236 M | 243 M | 243 M | 243 M | 243 M | 243 M | 243 M | 242 M | 241 M | 206 M | 180 M | - | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 180 M | 179 M | 179 M | 179 M | 179 M | 178 M | 181 M | 181 M | 182 M | 182 M | 182 M | 183 M | 185 M | 185 M | 185 M | 185 M | 186 M | 186 M | 186 M | 186 M | 185 M | 185 M | 185 M | 185 M | 185 M |
Net Income |
263 M | 193 M | 227 M | 226 M | 169 M | 217 M | 194 M | 153 M | 152 M | 92 M | 99 M | - | 12 M | 112 M | 82 M | - | 82 M | 113 M | 87 M | 148 M | 37 M | 31 M | 38 M | 118 M | 65 M | 139 M | 79 M | 225 M | 130 M | 115 M | 79 M | 71 M | 105 M | 99 M | 56 M | 50 M | 73 M | 71 M | 66 M | 114 M | 88 M | 74 M | 64 M | 96 M | 106 M | 86 M | 49 M | 68 M | 73 M | 46 M | 41 M | 73 M | 72 M | 89 M | 63 M | 52 M | 77 M | 72 M | 78 M |
Revenue |
2.34 B | 2.12 B | 2.27 B | 2.3 B | 2.07 B | 2.1 B | 2.17 B | 2.03 B | 2.08 B | 1.72 B | 1.45 B | - | 1.38 B | 1.36 B | 1.27 B | - | 1.26 B | 1.35 B | 1.26 B | 1.37 B | 1.22 B | 1.16 B | 1.12 B | 1.37 B | 1.3 B | 1.34 B | 1.24 B | 1.39 B | 1.29 B | 1.32 B | 1.22 B | 1.28 B | 1.2 B | 1.16 B | 1.07 B | 1.1 B | 897 M | 932 M | 847 M | 994 M | 902 M | 920 M | 837 M | 1.04 B | 963 M | 1 B | 906 M | 1.03 B | 965 M | 960 M | 879 M | 969 M | 931 M | 966 M | 925 M | 1 B | 939 M | 971 M | 890 M |
Cost of Revenue |
1.37 B | 1.32 B | 1.38 B | 1.41 B | 1.3 B | 1.32 B | 1.35 B | 1.28 B | 1.31 B | 1.07 B | 902 M | - | 856 M | 844 M | 805 M | - | 793 M | 831 M | 766 M | - | 759 M | 726 M | 714 M | - | 787 M | 819 M | 763 M | - | 782 M | 798 M | 757 M | - | 724 M | 707 M | 659 M | - | 540 M | 563 M | 518 M | - | 551 M | 572 M | 522 M | - | 587 M | 617 M | 564 M | - | 581 M | 589 M | 545 M | - | 557 M | 583 M | 562 M | - | 574 M | 592 M | 553 M |
Gross Profit |
963 M | 803 M | 883 M | 892 M | 768 M | 784 M | 819 M | 752 M | 764 M | 651 M | 546 M | - | 524 M | 520 M | 467 M | - | 472 M | 520 M | 490 M | 526 M | 461 M | 434 M | 409 M | 537 M | 509 M | 526 M | 474 M | 542 M | 505 M | 519 M | 460 M | 507 M | 471 M | 457 M | 412 M | 406 M | 357 M | 369 M | 329 M | 390 M | 351 M | 348 M | 315 M | 407 M | 376 M | 388 M | 342 M | 410 M | 384 M | 371 M | 334 M | 382 M | 374 M | 383 M | 363 M | 380 M | 365 M | 379 M | 337 M |
Operating Income |
390 M | 244 M | 334 M | 305 M | 231 M | 280 M | 253 M | 209 M | 191 M | 119 M | 131 M | - | 168 M | 146 M | 111 M | - | 152 M | 160 M | 133 M | 179 M | 73 M | 54 M | 61 M | 195 M | 11 M | 171 M | 109 M | 194 M | 176 M | 171 M | 113 M | 177 M | 152 M | 137 M | 86 M | 109 M | 109 M | 109 M | 79 M | 142 M | 120 M | 104 M | 83 M | 141 M | 130 M | 116 M | 76 M | 129 M | 98 M | 70 M | 66 M | 104 M | 111 M | 129 M | 99 M | 100 M | 79 M | 116 M | 100 M |
Interest Expense |
-3 M | - | 6 M | 3 M | 4 M | 10 M | 4 M | 6 M | 14 M | 12 M | 9 M | - | 12 M | 12 M | 13 M | - | 21 M | 21 M | 21 M | - | 22 M | 18 M | 16 M | - | 16 M | 18 M | 18 M | - | 21 M | 21 M | 21 M | - | 21 M | 21 M | 20 M | - | 16 M | 20 M | 14 M | - | 13 M | 14 M | 14 M | - | 14 M | 13 M | 14 M | - | 14 M | 14 M | 13 M | - | 14 M | 13 M | 14 M | - | 1 M | 1 M | 1 M |
EBITDA |
520 M | 309 M | 535 M | 381 M | 299 M | 421 M | 336 M | 270 M | 338 M | 211 M | 191 M | - | 226 M | 205 M | 169 M | - | 214 M | 222 M | 195 M | 179 M | 136 M | 116 M | 125 M | 195 M | 76 M | 234 M | 173 M | 194 M | 239 M | 236 M | 180 M | 177 M | 210 M | 194 M | 145 M | 109 M | 141 M | 142 M | 111 M | 142 M | 153 M | 138 M | 118 M | 141 M | 165 M | 152 M | 112 M | 129 M | 134 M | 107 M | 103 M | 104 M | 147 M | 162 M | 133 M | 100 M | 115 M | 151 M | 133 M |
General and Administrative Expenses |
503 M | 472 M | 474 M | 503 M | 460 M | 445 M | 485 M | 474 M | 491 M | 446 M | 354 M | - | 294 M | 314 M | 304 M | - | 273 M | 304 M | 301 M | - | 266 M | 288 M | 297 M | - | 273 M | 294 M | 303 M | - | 279 M | 293 M | 296 M | - | 270 M | 270 M | 272 M | - | 219 M | 227 M | 219 M | - | 207 M | 218 M | 206 M | - | 222 M | 242 M | 224 M | - | 257 M | 253 M | 237 M | - | 231 M | 220 M | 231 M | - | 215 M | 219 M | 210 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Xylem (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Britain
China
